Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Zepzelca (Lurbinectedin) Medicine in India

Buy Zepzelca (Lurbinectedin) Medicine in India

Zepzelca (Lurbinectedin)

Medicine name : Zepzelca

Generic name : Lurbinectedin

Manufactured By : Jazz

Indications : mSCLC

Medicine Description : Zepzelca is an alkylating agent for small cell lung cancer (SCLC). It binds to DNA, disrupting cancer cell replication. Given via IV infusion, it offers an alternative for resistant cases. Side effects include fatigue, low blood counts, nausea, and liver toxicity. Blood tests and liver function monitoring are required.

Product Introduction

Zepzelca (Lurbinectedin) is an anticancer treatment used to treat adults with metastatic small cell lung cancer (SCLC) whose disease has progressed during or after treatment with platinum-based chemotherapy. It works by binding to DNA and interfering with the processes needed for cancer cells to grow and multiply, helping slow disease progression.

Zepzelca (Lurbinectedin) is administered as an intravenous infusion by a qualified healthcare professional according to the treatment schedule prescribed by your doctor. Your doctor may perform blood tests before and during treatment to monitor blood cell counts and liver function. Do not miss scheduled appointments or change the treatment schedule without medical advice.

Common side effects of Zepzelca (Lurbinectedin) may include fatigue, decreased appetite, nausea, constipation, vomiting, diarrhea, decreased blood cell counts, and increased liver enzymes. It may also cause serious bone marrow suppression or liver problems. Inform your doctor promptly if you develop fever, unusual bleeding or bruising, yellowing of the skin or eyes, dark urine, or other severe or persistent symptoms.

Uses Of Zepzelca (Lurbinectedin)

Treatment of Metastatic Small Cell Lung Cancer

Benefits Of Zepzelca

Zepzelca (Lurbinectedin) is used to treat adults with metastatic small cell lung cancer (SCLC) whose disease has progressed during or after platinum-based chemotherapy. It interferes with cancer cell DNA and gene transcription, helping slow the growth and spread of cancer cells and control disease progression.

Side Effects Of Zepzelca (Lurbinectedin)

Most side effects do not require medical attention and may improve as your body adjusts to the treatment. Consult your doctor if they persist, become severe, or cause concern.

Common Side Effects of Zepzelca (Lurbinectedin)

  • Fatigue
  • Decreased appetite
  • Nausea
  • Constipation
  • Vomiting
  • Diarrhea
  • Decreased white blood cell count
  • Decreased platelet count
  • Anemia
  • Increased liver enzymes
How To Use Zepzelca

Zepzelca (Lurbinectedin) is administered as an intravenous infusion by a qualified healthcare professional according to the treatment schedule prescribed by your doctor. Blood tests are performed before and during treatment to monitor blood cell counts and liver function. Your doctor may also prescribe medicines to help prevent nausea and vomiting. Do not change or stop treatment without consulting your doctor.

How Zepzelca (Lurbinectedin) Works

Zepzelca (Lurbinectedin) works by binding to DNA and interfering with gene transcription, a process cancer cells need to produce proteins and grow. It also affects the tumor-supporting environment and can promote the death of cancer cells, helping slow the growth and spread of small cell lung cancer.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Avoid or limit alcohol during treatment unless your doctor advises otherwise, as it may worsen fatigue, nausea, or other side effects.

PregnancyCONSULT YOUR DOCTOR

Zepzelca may harm an unborn baby. Inform your doctor if you are pregnant, planning to become pregnant, or could become pregnant. Use effective contraception as advised by your doctor.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Zepzelca and for the recommended period after the final dose, as advised by your healthcare professional.

DrivingCONSULT YOUR DOCTOR

Zepzelca may cause fatigue, dizziness, or weakness. Avoid driving or operating machinery if you feel affected.

KidneyCAUTION

Inform your doctor if you have kidney problems. Your healthcare team will monitor your condition and determine whether Zepzelca is appropriate for you.

LiverCAUTION

Tell your doctor if you have liver problems. Liver function should be monitored during treatment because Zepzelca can affect the liver.

Quick Tips
  • Attend all scheduled Zepzelca (Lurbinectedin) infusions and follow your doctor's treatment schedule carefully.
  • Attend regular blood tests to monitor blood cell counts and liver function during treatment.
  • Report fever, chills, unusual bleeding, or bruising promptly, as these may indicate serious complications.
  • Follow your doctor's instructions for medicines prescribed to prevent nausea and vomiting.
  • Report yellowing of the skin or eyes, dark urine, severe fatigue, or other worsening symptoms promptly.
  • Read More About - Zepzelca (Lurbinectedin) from Pharma Five.
Faq

General Question

Zepzelca (Lurbinectedin) is a prescription drug used to treat small cell lung cancer (SCLC) that has progressed after prior chemotherapy.

Zepzelca works by interfering with cancer cell DNA, preventing the cells from growing and multiplying.

Doctors prescribe Zepzelca for adults with metastatic SCLC whose disease has worsened after platinum-based chemotherapy.

Zepzelca is given as an intravenous (IV) infusion, usually once every 21 days, under medical supervision.

Common side effects of Zepzelca include nausea, fatigue, decreased appetite, constipation, and low white blood cell count.

Yes, Zepzelca may cause severe bone marrow suppression, liver problems, or lung inflammation. Seek medical attention for any unusual symptoms.

Zepzelca is typically continued as long as it remains effective and well-tolerated or until the doctor advises stopping.

It is best to avoid alcohol while on Zepzelca, as it may worsen liver toxicity and side effects like nausea.

No, Zepzelca may harm an unborn baby. Women should use effective contraception while receiving this treatment.

Yes, Zepzelca may interact with certain antibiotics, antifungals, and seizure medications. Inform your doctor about all medicines you take.

If you miss a dose, consult your doctor immediately to reschedule your infusion. Do not take extra doses on your own.

Since Zepzelca is given as an IV infusion, food does not directly affect its administration. However, a balanced diet can help manage side effects.

Regular blood tests, avoiding infections, and reporting any unusual symptoms to your doctor are important while on Zepzelca treatment.

Zepzelca is stored in a medical facility under proper conditions and should not be kept at home.

Zepzelca is available through hospital pharmacies and specialty drug providers. Consult your doctor for the best source. Pharma Five assists in its procurement.